The PL-Touch Erchonia laser is a FDA-approved low level laser that effectively combats pain using the power of light!
The PL-Touch is a non-invasive, painless, sterile, drug-free laser that speeds the healing process by encouraging cell regeneration. Treatment with the laser also improves range of motion and decreases inflammation.
Erchonia is the global leader in low level laser healthcare applications and was the first to receive FDA market clearance for the treatment of chronic pain. Erchonia lasers have also been proven effective for the treatment of post-operative pain, body contouring, acne, and cellulite reduction.
Low-level laser therapy is the use of low intensity photonic energy as a treatment modality. Photonic stimuli excite the body’s cells infusing them with energy, with the three primary reactions being, reduction of inflammation, cell regeneration, and increased blood flow. Unlike the heat lasers, which are used in surgery to cut problem tissue, the low level laser does not generate heat and destroy tissue; instead it stimulates healing.
No, not all low level lasers are the same. Erchonia is the global leader in low level laser healthcare applications and research. Erchonia was also the first to receive FDA market clearance for the treatment of chronic pain with low level lasers.
Low level laser therapy is extremely safe. Low level lasers have been proven completely safe in over 3,000 worldwide studies. In fact, there isn’t one known adverse effect associated with low level laser therapy and there are no code regulated contraindications to treatment. Additionally, all Erchonia lasers are tested to ensure safety. All the lasers are developed, designed, and manufactured in accordance to both FDA and International Standards for Medical Device Quality Standards.
During treatment, most patients do not feel a thing, though some have reported a slight tingling sensation or a sense of deep relaxation after the treatment.
HOW CAN LASER THERAPY HELP ME?
Low level laser therapy is a non-invasive, fast and effective modality that has been proven in clinical trials to reduce pain, reduce edema, and promote healing. The potential applications of low-level laser are almost limitless, however; to date Erchonia has received FDA market clearance for neck and shoulder pain, breast augmentation, acne, laser assisted liposuction, non-invasive body contouring, and plantar fasciitis pain. Low level laser therapy has also been beneficial for patients with:
Minor nerve damage
Carpal tunnel syndrome
Chronic or acute pain
Heavy metal detoxification
The depth of penetration is dependent on multiple factors including mass and density. However, since low level laser has been proven in clinical studies to effect subcutaneous cells; the point is low-level laser, does penetrate; as opposed to the heat lamp devices that do not.
Low level laser therapy is not a new technology; in fact, light-based therapy dates back as far as 1,500 BC when Egyptian cultures built solariums at the top of mountain ranges to harness ultraviolet light to treat certain skin disorders. Laser therapy has been studied extensively starting in the early 1960’s and has earned over 1,500 peer reviewed publications. The one limitation of this application has always been the delivery mechanism, in order to generate a coherent light source in which the photons move in parallel with each other a small dot was required, obviously not practical within a clinical setting. Although an extensive body of research highlighted the efficacy of this technology it was simply not practical. However, in 1998 Erchonia designed the first line‐generated coherent laser light source which enabled clinicians to treat with an appropriate photon configuration over an acceptable surface area. Although this innovative mechanism provided functionality to low level laser therapy, the science in which it operates under is relatively new and presently not taught within healthcare-related institutions. Everyday, more and more physicians are observing the benefits of this technology, and as new studies are published which illustrate the therapeutic benefit of this application more physicians are embracing this technology. Presently, laser therapy is used across a wide‐assortment of medical disciplines to treatment a diverse arrangement of medical ailments.
This number of treatments is dependent on the condition and the application of the laser, however progress is immediately evident. In fact, just one treatment of laser therapy can generate a significant improvement in pain, impact cell proliferation, protein synthesis, and increase blood flow. Low level laser therapy addresses the underlining condition and results can last until the tissue is re‐aggravated. Clinical studies demonstrate that the positive outcomes associated with laser therapy are immediate and can last many weeks but like many therapies laser requires numerous treatments to effectively resolve the underlining etiologies responsible for producing pain. Treating the point of injury can dramatically improve blood and oxygen flow, downregulate pro‐inflammatory cytokines, and promote muscle activation and strength, but if the injury is not resolved inevitably these beneficial components will become overwhelmed and the pain will return. Coupled with preventive care a treatment series with low‐level laser therapy delivered by a trained professional can generate long‐term results.